FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/02/2024
Back to search
Official data from USPTO
SPYBIOTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SPYBIOTECH
ST13
US500000079975699Class
5, 42
Filing
79975699
Registration
7153093
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
01/02/2024
Trademark type
Word
Nice classes
5, 42
Filing date
08/18/2021
Registration date
09/05/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/05/2023
Last transaction
09/05/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
CLARK, ANDREW
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SPYBIOTECH LIMITED
Representatives
Ben Natter Haug Partners, LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalbiopharmaceutical and medicinal preparations and substances for the treatment of ophthalmological conditionshearing losshematologic diseasesimmune response disordersneurological disordersrespiratory diseasesfibrosishepatic diseasesrenal diseasesdiseases of the pancreasmetabolic diseasesgenetic conditionscancerinfectious diseases and cardiovascular diseases; vaccines; vaccine preparations; all of the foregoing for exclusive use in the vaccine and viral based therapeutics field
Class 42
Medical and pharmaceutical research services; biological research; development of pharmaceutical preparations and medicines; research and development relating to biologics and vaccines; providing medical and scientific research information in the field of pharmaceuticals and vaccines; scientific research in the nature of conducting clinical trials for others in the vaccine and viral based therapeutics field; scientific and medical research consulting services in the nature of clinical trial design for vaccines for others; providing a bioinformatics platform for use in manufacturing therapeutics in the nature of platform as a service (PAAS) featuring computer software for medical data analysis; scientific services relating to the discoverypreclinical and clinical development of vaccines and therapeutic products in the nature of development of pharmaceutical preparations and medicines; research and development of new products for others; development of pharmaceutical products for others; informationadvisory and consultancy services relating to the aforesaid
Publications
History of USPTO decisions and trademark events.
42 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/07/2023
FIMP
FINAL DISPOSITION PROCESSED
12/07/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/05/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/05/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
09/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/20/2023
PUBO
PUBLISHED FOR OPPOSITION
06/20/2023
GPNX
NOTIFICATION PROCESSED BY IB
06/19/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/31/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/31/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/31/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/17/2023
MNDA
NOTICE OF DIVIDED TRADEMARK APPLICATION MAILED
04/18/2023
DPCC
DIVISIONAL PROCESSING COMPLETE
04/12/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/12/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/04/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/15/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/15/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/15/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/13/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/13/2023
DRRR
DIVISIONAL REQUEST RECEIVED
02/27/2023
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
02/27/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/13/2023
GNFR
FINAL REFUSAL E-MAILED
01/13/2023
CNFR
FINAL REFUSAL WRITTEN
01/13/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/21/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/21/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/21/2022
RFNT
REFUSAL PROCESSED BY IB
07/19/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/28/2022
RFRR
REFUSAL PROCESSED BY MPU
06/28/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/15/2022
CNRT
NON-FINAL ACTION WRITTEN
06/14/2022
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
06/13/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/07/2022
CNRT
NON-FINAL ACTION WRITTEN
06/06/2022
DOCK
ASSIGNED TO EXAMINER
05/20/2022
MAFR
APPLICATION FILING RECEIPT MAILED
10/19/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/15/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/14/2021
Continuous trademark protection
Get notified about every new filing that threatens SPYBIOTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.